Abaloparatide approved

'Bone Up' por Dr Richie Abel (PhD) and Prof David Armstrong (MD)

Notas del episodio

The lads talked to each other about the exciting news that the National Institute for Health and Care Excellence (Nice) announced it had approved a new drug, Abaloparatide, for use by the health service. It will be available for use on the NHS in England within three months.

Palabras clave
osteoporosisfracture riskboneimminent fracturefracture liason servicefracturehip fracturefragility fractures